Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
20.99
-0.36 (-1.69%)
At close: May 15, 2026, 4:00 PM EDT
21.05
+0.06 (0.29%)
After-hours: May 15, 2026, 7:58 PM EDT
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$2,240,972
Market Cap
2.29B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 106 | 32 | 43.24% | 105 | 1 |
| Dec 31, 2024 | 74 | 17 | 29.82% | 74 | 0 |
| Dec 31, 2023 | 57 | 9 | 18.75% | 57 | 0 |
| Dec 31, 2022 | 48 | 7 | 17.07% | 48 | 0 |
| Dec 31, 2021 | 41 | 19 | 86.36% | 41 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Ultragenyx Pharmaceutical | 1,371 |
| Celldex Therapeutics | 198 |
| Relay Therapeutics | 192 |
| Immunome | 177 |
| IDEAYA Biosciences | 145 |
| Kodiak Sciences | 130 |
| Tyra Biosciences | 87 |
DFTX News
- 3 days ago - Definium Therapeutics says first patient dosed in Ascend study - TheFly
- 4 days ago - Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder - Business Wire
- 4 days ago - Definium Therapeutics Announces New Employee Inducement Grants - Business Wire
- 8 days ago - Definium Therapeutics price target lowered to $48 from $49 at Piper Sandler - TheFly
- 8 days ago - Definium Therapeutics reports Q1 EPS (71c), consensus (49c) - TheFly
- 8 days ago - Definium Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 8 days ago - Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights - Business Wire
- 15 days ago - Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire